Trials / Completed
CompletedNCT00273455
Lumigan Versus Cosopt
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (planned)
- Sponsor
- Pharmaceutical Research Network · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bimatoprost 0.03% | |
| DRUG | dorzolamide 2%/timolol maleate 0.5% fixed combination | |
| DRUG | placebo |
Timeline
- Start date
- 2006-01-01
- Completion
- 2007-05-01
- First posted
- 2006-01-09
- Last updated
- 2008-11-19
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00273455. Inclusion in this directory is not an endorsement.